Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 7;14(1):42.
doi: 10.1038/s41408-024-01004-y.

Regulation of HOX gene expression in AML

Affiliations
Review

Regulation of HOX gene expression in AML

Irum Khan et al. Blood Cancer J. .

Abstract

As key developmental regulators, HOX cluster genes have varied and context-specific roles in normal and malignant hematopoiesis. A complex interaction of transcription factors, epigenetic regulators, long non-coding RNAs and chromatin structural changes orchestrate HOX expression in leukemia cells. In this review we summarize molecular mechanisms underlying HOX regulation in clinical subsets of AML, with a focus on NPM1 mutated (NPM1mut) AML comprising a third of all AML patients. While the leukemia initiating function of the NPM1 mutation is clearly dependent on HOX activity, the favorable treatment responses in these patients with upregulation of HOX cluster genes is a poorly understood paradoxical observation. Recent data confirm FOXM1 as a suppressor of HOX activity and a well-known binding partner of NPM suggesting that FOXM1 inactivation may mediate the effect of cytoplasmic NPM on HOX upregulation. Conversely the residual nuclear fraction of mutant NPM has also been recently shown to have chromatin modifying effects permissive to HOX expression. Recent identification of the menin-MLL interaction as a critical vulnerability of HOX-dependent AML has fueled the development of menin inhibitors that are clinically active in NPM1 and MLL rearranged AML despite inconsistent suppression of the HOX locus. Insights into context-specific regulation of HOX in AML may provide a solid foundation for targeting this common vulnerability across several major AML subtypes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. General and context-specific mechanisms of HOX regulation in AML.
A Major mechanisms of regulation of expression of HOX A/B genes in human leukemia cells include (i) cytogenetic rearrangements resulting in novel fusion proteins, (ii) long non-coding RNA association with the HOX gene locus and (iii) binding of upstream protein such as CDX proteins. B Regulation of HOX A in the context of NPM1mut AML includes two discrete mechanisms whereby (i) residual nuclear mutant NPM1 directly binds to chromatin and hijacks the transcriptional complex (RNA Pol II, MLL-Menin and super elongation complex) and (ii) the bulk of mutant NPM1 sequesters and relocalizes to the cytoplasm several repressors of HOX gene expression including FOXM1, and PU.1. * Additional cytogenetic arrangements inducing HOX expression include NUP98-NSD1, SET -NUP214, DEK-NUP214.

Similar articles

Cited by

References

    1. Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209–21. doi: 10.1056/NEJMoa1516192. - DOI - PMC - PubMed
    1. Kelly LM, Gilliland DG. Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet. 2002;3:179–98. doi: 10.1146/annurev.genom.3.032802.115046. - DOI - PubMed
    1. Moore MA. Converging pathways in leukemogenesis and stem cell self-renewal. Exp Hematol. 2005;33:719–37. doi: 10.1016/j.exphem.2005.04.011. - DOI - PubMed
    1. Wiseman DH, Greystoke BF, Somervaille TC. The variety of leukemic stem cells in myeloid malignancy. Oncogene. 2014;33:3091–8. doi: 10.1038/onc.2013.269. - DOI - PubMed
    1. Assi SA, Imperato MR, Coleman DJL, Pickin A, Potluri S, Ptasinska A, et al. Subtype-specific regulatory network rewiring in acute myeloid leukemia. Nat Genet. 2019;51:151–62. doi: 10.1038/s41588-018-0270-1. - DOI - PMC - PubMed